Literature DB >> 17312499

Increasing incidence of methicillin-resistant Staphylococcus aureus in hand infections: a 3-year county hospital experience.

Danielle M LeBlanc1, Edward M Reece, J Bauer Horton, Jeffrey E Janis.   

Abstract

BACKGROUND: Staphylococcus aureus is the most common cause of skin and soft-tissue infections. Methicillin-resistant S. aureus and community-acquired methicillin-resistant S. aureus have shown an increase in prevalence among soft-tissue infections over the past several years, with overall rates approaching 50 percent at the authors' institution in 2002. The object of this study was to determine the incidence of methicillin-resistant S. aureus with respect to hand infections, the antibiotic resistance pattern of methicillin-resistant S. aureus isolates, and implications for a change in antibiotic treatment algorithms for hand infections.
METHODS: A retrospective chart review of 761 patients with hand infections tracked by International Classification of Diseases, 9th Revision codes for finger or hand abscesses from 2001 to 2003 was performed at Parkland Memorial Hospital, Dallas, Texas. Culture results were obtained from 436 patients and analyzed for type of organism, and sensitivity profiles were obtained for all methicillin-resistant S. aureus isolates.
RESULTS: The median age of 761 patients was 40 years (range, 16 to 77 years); 71 percent were male and 28 percent were female. Of the 436 cultures reviewed, 371 (85 percent) had organisms identified. Methicillin-resistant S. aureus was the dominant single organism in hand infections cultured in all 3 years. The overall methicillin-resistant S. aureus rate was 61 percent of all hand infections in 2003. The percentage of S. aureus isolates identified as methicillin-resistant S. aureus increased from 55 percent to 78 percent over 3 years, up from 34 percent in 2001. Fortunately, 86 percent of these methicillin-resistant S. aureus isolates demonstrated sensitivity to conventional antibiotics, but a trend of resistance is developing.
CONCLUSIONS: The incidence of community-acquired methicillin-resistant S. aureus increased from 34 percent to 61 percent over a 3-year period at the authors' county institution. An increasing trend of resistance patterns among conventional antibiotics was also demonstrated. As a result of this study, the treatment algorithm at Parkland Memorial Hospital has been modified to include abscess drainage accompanied by an antibiotic regimen targeted specifically at methicillin-resistant S. aureus. These data also have implications for broader application regarding simple skin infections and current antibiotic treatment algorithms.

Entities:  

Mesh:

Year:  2007        PMID: 17312499     DOI: 10.1097/01.prs.0000252270.84195.41

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  5 in total

1.  Ecological succession and viability of human-associated microbiota on restroom surfaces.

Authors:  Sean M Gibbons; Tara Schwartz; Jennifer Fouquier; Michelle Mitchell; Naseer Sangwan; Jack A Gilbert; Scott T Kelley
Journal:  Appl Environ Microbiol       Date:  2014-11-14       Impact factor: 4.792

2.  Impact of methicillin-resistant Staphylococcus aureus on treatment of hand infections.

Authors:  Scott D Lifchez; David A Harriman
Journal:  Eplasty       Date:  2009-11-20

3.  A Nationwide Epidemiological Analysis of Finger Infections Presenting to Emergency Departments in the United States From 2012 to 2016.

Authors:  Nicholas J Lemme; Neill Y Li; Edward J Testa; Alexander S Kuczmarski; Jacob Modest; Julia A Katarincic; Joseph A Gil
Journal:  Hand (N Y)       Date:  2020-05-01

4.  Optimizing Treatment of Hand Infections: Is MRSA Coverage Always Necessary?

Authors:  Jeremie D Oliver; Brian C Pridgen; Heather E desJardins-Park; Catherine Curtin; Paige M Fox
Journal:  Plast Reconstr Surg Glob Open       Date:  2021-06-15

5.  Hand infections: a retrospective analysis.

Authors:  Tolga Türker; Nicole Capdarest-Arest; Spencer T Bertoch; Erik C Bakken; Susan E Hoover; Jiyao Zou
Journal:  PeerJ       Date:  2014-09-02       Impact factor: 2.984

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.